Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
The Pituitary Gland01:17

The Pituitary Gland

The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining Acquired Hypothalamic Obesity: An Expert Call for Unified Diagnosis and Therapeutic Action.

Diabetes, obesity & metabolism·2026
Same author

Genetic testing in "Mild Growth Hormone Deficiency".

European journal of endocrinology·2026
Same author

Mapping the anatomical and transcriptional landscape of early human fetal ovary development.

Scientific reports·2025
Same author

Transcriptomic sex differences in early human fetal brain development.

Communications biology·2025
Same author

A Tiered Approach to Exome Sequencing Analysis in Early-Onset Primary Ovarian Insufficiency.

The Journal of clinical endocrinology and metabolism·2025
Same author

Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication.

Therapeutic advances in endocrinology and metabolism·2024

Related Experiment Video

Updated: Jul 8, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
09:48

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology

Published on: February 25, 2022

Hypopituitarism oddities: congenital causes.

Daniel Kelberman1, Mehul T Dattani

  • 1Developmental Endocrinology Research Group, Institute of Child Health, London, UK.

Hormone Research
|February 7, 2008
PubMed
Summary
This summary is machine-generated.

Genetic mutations in key developmental genes cause hypopituitarism, often with variable syndromic features. Understanding these genetic causes is crucial for predicting disease evolution and patient outcomes.

More Related Videos

Dissection and Coronal Slice Preparation of Developing Mouse Pituitary Gland
06:53

Dissection and Coronal Slice Preparation of Developing Mouse Pituitary Gland

Published on: November 16, 2017

Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

Related Experiment Videos

Last Updated: Jul 8, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
09:48

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology

Published on: February 25, 2022

Dissection and Coronal Slice Preparation of Developing Mouse Pituitary Gland
06:53

Dissection and Coronal Slice Preparation of Developing Mouse Pituitary Gland

Published on: November 16, 2017

Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

Area of Science:

  • Endocrinology
  • Developmental Biology
  • Genetics

Background:

  • Significant advancements in understanding hypothalamo-pituitary development over the last 15 years, primarily from animal models.
  • A complex genetic cascade governs anterior pituitary organ commitment, cell differentiation, and proliferation.
  • Mutations in genes like HESX1, LHX3, LHX4, PROP1, POU1F1, SOX3, and SOX2 are implicated in hypopituitarism etiology.

Purpose of the Study:

  • To review the genetic basis of hypopituitarism, focusing on mutations affecting anterior pituitary development.
  • To highlight the variable clinical phenotypes and extrapituitary features associated with these genetic defects.
  • To emphasize the importance of detailed clinical, biochemical, and neuroradiological assessment in guiding genetic studies.

Main Methods:

  • Review of naturally-occurring and transgenic animal models.
  • Analysis of human genetic mutations in key developmental genes.
  • Correlation of genotype with clinical, biochemical, and neuroradiological phenotypes.

Main Results:

  • Mutations in HESX1, SOX3, and SOX2 can lead to hypopituitarism with diverse extrapituitary manifestations (e.g., septo-optic dysplasia, learning difficulties, anophthalmia).
  • LHX3 mutations are associated with specific hormone deficiencies (GH, TSH, LH, FSH) and a characteristic short, stiff neck.
  • PROP1 and POU1F1 mutations cause combined pituitary hormone deficiency (CPHD) with variable pituitary morphology and potential for evolving ACTH deficiency.

Conclusions:

  • Future research will integrate genetic and functional analyses to elucidate mechanisms of hypopituitary phenotypes and predict disease progression.
  • Comprehensive clinical, biochemical, and neuroradiological phenotyping is essential before genetic investigations.
  • Understanding genotype-phenotype correlations is key to managing hypopituitarism and its associated disorders.